The effect of pioglitazone on the liver: role of adiponectin.

Gastaldelli, Amalia; Miyazaki, Yoshinori; Mahankali, Archana; Berria, Rachele; Pettiti, Maura; Buzzigoli, Emma; Ferrannini, Eleuterio; DeFronzo, Ralph A

Gastaldelli, Amalia; Miyazaki, Yoshinori; Mahankali, Archana; Berria, Rachele; Pettiti, Maura; Buzzigoli, Emma; Ferrannini, Eleuterio; DeFronzo, Ralph A.

Affiliation

Gastaldelli A; Stable Isotope Lab, Institute of Clinical Physiology-CNR, via Moruzzi 1, 56100 Pisa, Italy. amalia@ifc.cnr.it

Diabetes Care ; 29(10): 2275-81, 2006 Oct.

Article in En | MEDLINE | ID: mdl-17003306

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Liver/drug effects; Thiazolidinediones/therapeutic use; Abdominal Fat/drug effects; Adiponectin/blood; Gluconeogenesis/drug effects; Glucose/biosynthesis; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin/blood; Liver Glycogen; Middle Aged; PPAR gamma/agonists; Pioglitazone; Sulfonylurea Compounds/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thiazolidinediones / Diabetes Mellitus, Type 2 / Liver Type of study: Clinical_trials Limits: Humans / Middle aged Language: En Journal: Diabetes Care Year: 2006 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links